Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / COM PAR
-
Total 13F shares
-
951,384
-
Share change
-
+70,437
-
Total reported value
-
$9,178,510
-
Price per share
-
$9.65
-
Number of holders
-
25
-
Value change
-
+$680,955
-
Number of buys
-
8
-
Number of sells
-
10
Institutional Holders of IMMUCELL CORP /DE/ - COM PAR (ICCC) as of Q1 2022
As of 31 Mar 2022,
IMMUCELL CORP /DE/ - COM PAR (ICCC) was held by
25 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
951,384 shares.
The largest 10 holders included
VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, Meristem Family Wealth, LLC, SHUFRO ROSE & CO LLC, Bleichroeder LP, MORGAN STANLEY, OVERBROOK MANAGEMENT CORP, PERRITT CAPITAL MANAGEMENT INC, Strategic Financial Services, Inc,, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
25
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.